This session will present a structured, educational overview of how to perform patient-specific dosimetry in radiopharmaceutical therapy, using AAPM TG-381 as a reference framework. The first part will walk through generalizable dosimetry workflows—from imagi...
Author profile
David P. Adam, PhD, MS
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University
Dosimetry in Radiopharmaceutical Therapy: How to Do It
Invited Program · IM/TH- Radiopharmaceutical Therapy
Identifiability, Effective Dimensionality, and Interpretability In PBPK-Based Alpha Rpt Dosimetry
Quantitative image-based dosimetry for radiopharmaceutical therapy (RPT) increasingly relies on large, multi-organ mechanistic models of physiologically based pharmacokinetics (PBPK). While PBPK models often fit clinical data well, the extent to which their i...
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine
Microscale Histology-Informed Minipig Salivary Gland Model for Preclinical Radiopharmaceutical Dosimetry
In prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy for metastatic castration-resistant prostate cancer, salivary glands often receive unintended high absorbed doses and are considered dose-limiting organs. For radiopharmaceutica...
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine